{
  "id": 853198,
  "title": "U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma",
  "url": "https://urgent.news/2026/08/14/u-s-fda-issues-warning-letter-to-aurobindo-pharmas-subsidiary-eugia-853198",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-14T07:29:50.000Z",
  "source": {
    "name": "The Hindu Health",
    "slug": "the-hindu-health",
    "url": "https://www.thehindu.com/business/us-fda-issues-warning-letter-to-aurobindo-pharmas-subsidiary-eugia-pharma/article71344431.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu",
        "title": "U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma",
        "url": "https://urgent.news/2026/08/14/u-s-fda-issues-warning-letter-to-aurobindo-pharmas-subsidiary-eugia",
        "published": "2026-08-14T07:29:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}